CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ/ Stat3 axis

Overexpression of CAMKIIγ was associated with disease progression

Baseline clinical characteristics of the 94 patients with multiple

Frontiers Deregulated calcium signaling in blood cancer

In vitro and in vivo efficacy of the novel oral proteasome

Recent advances in targeting the “undruggable” proteins: from drug

Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib

PDF] CAMKIIγ is a targetable driver of multiple myeloma through

Overexpression of CAMKIIγ was associated with disease progression

Demystifying the Druggability of the MYC Family of Oncogenes

4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces

How selective are clinical CDK4/6 inhibitors? - Hendrychová - 2021

In silico analysis identified miRNA‑based therapeutic agents

CIMB, Free Full-Text

In silico analysis identified miRNA‑based therapeutic agents

4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces